Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 52.18

-2.5%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who started this subject	9/16/2000 8:44:11 PM
From: enervestor	Read Replies (1) of 52153

Peter, I noticed your message about owniing some QTRN. I don't own any of the CRO's, but have been thinking they could be compelling investments. They have been ignored in the biotech run-up and most are still extremely cheap. I suppose they are still reflecting the money problems of the biotech industry of the past several of years. Looking at them as an outside investor, it would seem the now cash-flush biotechs would be flowing money to them now, but their stock prices don't reflect that happening. Does anyone on this thread know if they are being left out or just overlooked? What is the timeline from biotechs cashing in on secondaries and the money flowing to the CRO's? Thanks to anyone who can shed some light on these questions.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next